Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Natco Pharma Ltd. Earnings Release 2020

Jun 17, 2020

62741_rns_2020-06-17_bfadd85e-d651-4378-800b-49b1f4ee5fa7.pdf

Earnings Release

Open in viewer

Opens in your device viewer

==> picture [113 x 53] intentionally omitted <==

==> picture [112 x 54] intentionally omitted <==

Segment Revenue,Q4FY20 Revenue,Full Year
FY20
API 96.4 355.2
Formulations, Domestic 102.6 540.5
Formulations, Exports 200.9 824.9
(incl. ProfitShare)
Foreign Subsidiaries 18.5 108.5
Other Operatingincome 20.2 69.5
Other Income 38.6 123.8

More from Natco Pharma Ltd.

Regulatory Filings 2026
May 26
Regulatory Filings 2026
May 21
Regulatory Filings 2026
May 21
Regulatory Filings 2026
May 18
Legal Proceedings Report 2026
May 15
Legal Proceedings Report 2026
May 14
Regulatory Filings 2026
May 14
Major Shareholding Notification 2026
Apr 29
Regulatory Filings 2026
Apr 9
Regulatory Filings 2026
Apr 8
View all filings →